
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $12.3B | $13.7B | $14.4B | $15.4B | $16.7B | |
Revenue Growth (YoY) | 10.84% | 11.71% | 4.8% | 7.24% | 7.93% | |
Cost of Revenues | $10.6B | $11.7B | $12.3B | $13.2B | $13.9B | |
Gross Profit | $1.7B | $2B | $2.1B | $2.2B | $2.8B | |
Gross Profit Margin | 14.13% | 14.66% | 14.48% | 14.54% | 16.79% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $770M | $851M | $951M | $942M | $983M | |
Other Inc / (Exp) | -$7M | -$12M | -$48M | -$687M | $17M | |
Operating Expenses | $770M | $851M | $951M | $942M | $983M | |
Operating Income | $967M | $1.2B | $1.1B | $1.3B | $1.8B | |
Net Interest Expenses | $179M | $184M | $199M | $212M | $193M | |
EBT. Incl. Unusual Items | $781M | $967M | $886M | $403M | $1.6B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $152M | $208M | $193M | $195M | $388M | |
Net Income to Company | $629M | $759M | $693M | $208M | $1.3B | |
Minority Interest in Earnings | -$1M | -$6M | -$8M | -$9M | $3M | |
Net Income to Common Excl Extra Items | $628M | $753M | $685M | $199M | $1.3B | |
Basic EPS (Cont. Ops) | $4.42 | $5.34 | $5.00 | $1.45 | $9.36 | |
Diluted EPS (Cont. Ops) | $4.36 | $5.27 | $4.96 | $1.44 | $9.22 | |
Weighted Average Basic Share | $142M | $141M | $137M | $137M | $134M | |
Weighted Average Diluted Share | $144M | $143M | $138M | $138M | $136M | |
EBITDA | $1.2B | $1.5B | $1.4B | $946M | $2.1B | |
EBIT | $963M | $1.2B | $1.1B | $615M | $1.8B | |
Revenue (Reported) | $12.3B | $13.7B | $14.4B | $15.4B | $16.7B | |
Operating Income (Reported) | $967M | $1.2B | $1.1B | $1.3B | $1.8B | |
Operating Income (Adjusted) | $963M | $1.2B | $1.1B | $615M | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.3B | $3.5B | $3.7B | $4B | $4.2B | |
Revenue Growth (YoY) | 14.75% | 5.4% | 5.87% | 7.46% | 6.79% | |
Cost of Revenues | $2.8B | $3B | $3.2B | $3.3B | $3.5B | |
Gross Profit | $467M | $512M | $495M | $638M | $757M | |
Gross Profit Margin | 14.09% | 14.65% | 13.38% | 16.05% | 17.83% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $159M | $236M | $233M | $226M | $230M | |
Other Inc / (Exp) | -$1M | -$6M | -$1M | $5M | $7M | |
Operating Expenses | $159M | $236M | $233M | $226M | $230M | |
Operating Income | $308M | $276M | $262M | $412M | $527M | |
Net Interest Expenses | $45M | $48M | $54M | $49M | $49M | |
EBT. Incl. Unusual Items | $262M | $222M | $207M | $368M | $478M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $57M | $45M | $43M | $85M | $113M | |
Net Income to Company | $205M | $177M | $164M | $283M | $365M | |
Minority Interest in Earnings | -- | -$2M | -$2M | $1M | -$2M | |
Net Income to Common Excl Extra Items | $205M | $175M | $162M | $284M | $363M | |
Basic EPS (Cont. Ops) | $1.44 | $1.26 | $1.18 | $2.09 | $2.79 | |
Diluted EPS (Cont. Ops) | $1.42 | $1.25 | $1.17 | $2.07 | $2.77 | |
Weighted Average Basic Share | $142M | $139M | $137M | $136M | $130M | |
Weighted Average Diluted Share | $144M | $140M | $138M | $137M | $131M | |
EBITDA | $384M | $355M | $343M | $486M | $596M | |
EBIT | $307M | $270M | $261M | $417M | $527M | |
Revenue (Reported) | $3.3B | $3.5B | $3.7B | $4B | $4.2B | |
Operating Income (Reported) | $308M | $276M | $262M | $412M | $527M | |
Operating Income (Adjusted) | $307M | $270M | $261M | $417M | $527M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $12.7B | $13.9B | $14.6B | $15.7B | $16.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $10.9B | $11.9B | $12.5B | $13.3B | $14B | |
Gross Profit | $1.8B | $2.1B | $2.1B | $2.4B | $2.9B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $741M | $919M | $948M | $935M | $987M | |
Other Inc / (Exp) | $21M | -$26M | -$43M | -$674M | $19M | |
Operating Expenses | $741M | $919M | $948M | $935M | $987M | |
Operating Income | $1.1B | $1.1B | $1.1B | $1.5B | $1.9B | |
Net Interest Expenses | $176M | $187M | $205M | $207M | $193M | |
EBT. Incl. Unusual Items | $913M | $927M | $871M | $564M | $1.7B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $194M | $196M | $191M | $237M | $416M | |
Net Income to Company | $719M | $731M | $680M | $327M | $1.3B | |
Minority Interest in Earnings | -$1M | -$8M | -$8M | -$6M | -- | |
Net Income to Common Excl Extra Items | $718M | $723M | $672M | $321M | $1.3B | |
Basic EPS (Cont. Ops) | $5.06 | $5.15 | $4.90 | $2.36 | $10.04 | |
Diluted EPS (Cont. Ops) | $4.98 | $5.09 | $4.86 | $2.32 | $9.94 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.4B | $1.4B | $1.4B | $1.1B | $2.2B | |
EBIT | $1.1B | $1.1B | $1.1B | $771M | $1.9B | |
Revenue (Reported) | $12.7B | $13.9B | $14.6B | $15.7B | $16.9B | |
Operating Income (Reported) | $1.1B | $1.1B | $1.1B | $1.5B | $1.9B | |
Operating Income (Adjusted) | $1.1B | $1.1B | $1.1B | $771M | $1.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.3B | $3.5B | $3.7B | $4B | $4.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.8B | $3B | $3.2B | $3.3B | $3.5B | |
Gross Profit | $467M | $512M | $495M | $638M | $757M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $159M | $236M | $233M | $226M | $230M | |
Other Inc / (Exp) | -$1M | -$6M | -$1M | $5M | $7M | |
Operating Expenses | $159M | $236M | $233M | $226M | $230M | |
Operating Income | $308M | $276M | $262M | $412M | $527M | |
Net Interest Expenses | $45M | $48M | $54M | $49M | $49M | |
EBT. Incl. Unusual Items | $262M | $222M | $207M | $368M | $478M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $57M | $45M | $43M | $85M | $113M | |
Net Income to Company | $205M | $177M | $164M | $283M | $365M | |
Minority Interest in Earnings | -- | -$2M | -$2M | $1M | -$2M | |
Net Income to Common Excl Extra Items | $205M | $175M | $162M | $284M | $363M | |
Basic EPS (Cont. Ops) | $1.44 | $1.26 | $1.18 | $2.09 | $2.79 | |
Diluted EPS (Cont. Ops) | $1.42 | $1.25 | $1.17 | $2.07 | $2.77 | |
Weighted Average Basic Share | $142M | $139M | $137M | $136M | $130M | |
Weighted Average Diluted Share | $144M | $140M | $138M | $137M | $131M | |
EBITDA | $384M | $355M | $343M | $486M | $596M | |
EBIT | $307M | $270M | $261M | $417M | $527M | |
Revenue (Reported) | $3.3B | $3.5B | $3.7B | $4B | $4.2B | |
Operating Income (Reported) | $308M | $276M | $262M | $412M | $527M | |
Operating Income (Adjusted) | $307M | $270M | $261M | $417M | $527M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $524M | $727M | $516M | $777M | $943M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.3B | $1.2B | $1.4B | $1.4B | $1.8B | |
Inventory | $276M | $274M | $287M | $310M | $315M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $232M | $281M | $490M | $489M | $525M | |
Total Current Assets | $3.3B | $3.6B | $3.6B | $4B | $4.4B | |
Property Plant And Equipment | $1.2B | $1.3B | $1.4B | $1.5B | $1.6B | |
Long-Term Investments | $15M | $25M | -- | -- | -- | |
Goodwill | $6.3B | $6.7B | $6.7B | $6.1B | $6.1B | |
Other Intangibles | $1.2B | $1.2B | $952M | $667M | $517M | |
Other Long-Term Assets | $443M | $414M | $360M | $336M | $321M | |
Total Assets | $12.5B | $13.3B | $13.1B | $12.7B | $13.1B | |
Accounts Payable | $731M | $692M | $733M | $736M | $705M | |
Accrued Expenses | $1.6B | $1.7B | $1.8B | $1.8B | $2B | |
Current Portion Of Long-Term Debt | -- | $103M | $672M | $18M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $2.9B | $3.2B | $3.9B | $3B | $3.7B | |
Long-Term Debt | $4.6B | $4.6B | $3.9B | $4.7B | $4.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $8.6B | $8.9B | $8.7B | $8.4B | $8.6B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -$46M | -$12M | -$73M | -$48M | -$110M | |
Common Equity | $3.9B | $4.3B | $4.3B | $4.2B | $4.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $9M | $53M | $54M | $57M | $48M | |
Total Equity | $3.9B | $4.3B | $4.4B | $4.3B | $4.5B | |
Total Liabilities and Equity | $12.5B | $13.3B | $13.1B | $12.7B | $13.1B | |
Cash and Short Terms | $524M | $727M | $516M | $777M | $943M | |
Total Debt | $4.7B | $5.1B | $4.9B | $4.7B | $4.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $377M | $297M | $379M | $633M | $842M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $2.2B | $2.4B | $1.5B | $2.7B | $2.9B | |
Inventory | $268M | $279M | $300M | $318M | $347M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $452M | $492M | $356M | $486M | $454M | |
Total Current Assets | $3.3B | $3.5B | $3.7B | $4.2B | $4.5B | |
Property Plant And Equipment | $1.2B | $1.3B | $1.5B | $1.5B | $1.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $6.5B | $6.7B | $6.7B | $6.1B | $6.1B | |
Other Intangibles | $1.2B | $1.1B | $902M | $629M | $489M | |
Other Long-Term Assets | $452M | $418M | $399M | $474M | $543M | |
Total Assets | $12.6B | $13B | $13.1B | $12.8B | $13.2B | |
Accounts Payable | $2.1B | $2.2B | $1.8B | $2.3B | $2.2B | |
Accrued Expenses | $684M | $724M | $712M | $740M | $664M | |
Current Portion Of Long-Term Debt | -- | $101M | $19M | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $2.9B | $3.5B | $3.2B | $3.1B | $3B | |
Long-Term Debt | $4.7B | $4.6B | $4.7B | $4.6B | $5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $8.7B | $9B | $8.7B | $8.5B | $8.9B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -$37M | $20M | -$64M | -$72M | -$83M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $47M | $53M | $55M | $55M | $45M | |
Total Equity | $4B | $4B | $4.5B | $4.3B | $4.3B | |
Total Liabilities and Equity | $12.6B | $13B | $13.1B | $12.8B | $13.2B | |
Cash and Short Terms | $377M | $297M | $379M | $633M | $842M | |
Total Debt | $4.8B | $5.1B | $5B | $4.7B | $5.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $629M | $759M | $693M | $208M | $1.3B | |
Depreciation & Amoritzation | $282M | $325M | $333M | $331M | $290M | |
Stock-Based Compensation | $62M | $67M | $73M | $77M | $85M | |
Change in Accounts Receivable | -$127M | -$5M | -$174M | -$65M | -$220M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.3B | $1B | $992M | $1.2B | $1.4B | |
Capital Expenditures | $183M | $104M | $129M | $207M | $149M | |
Cash Acquisitions | -$2.7B | -$622M | -$177M | -$4M | -- | |
Cash From Investing | -$2.8B | -$730M | -$313M | -$211M | -$142M | |
Dividends Paid (Ex Special Dividend) | -$196M | -$199M | -$199M | -$201M | -$208M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $7.2B | $380M | $380M | $1.7B | -- | |
Long-Term Debt Repaid | -$5.5B | -$106M | -$545M | -$2B | -$18M | |
Repurchase of Common Stock | -$105M | -$270M | -$542M | -$246M | -$906M | |
Other Financing Activities | -$52M | $38M | -$7M | -$16M | -$7M | |
Cash From Financing | $1.5B | -$113M | -$865M | -$715M | -$1.1B | |
Beginning Cash (CF) | $717M | $687M | $875M | $683M | $928M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$30M | $190M | -$186M | $239M | $166M | |
Ending Cash (CF) | $687M | $727M | $516M | $777M | $943M | |
Levered Free Cash Flow | $1.2B | $929M | $863M | $958M | $1.2B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $170M | $172M | $210M | $324M | -- | |
Depreciation & Amoritzation | $80M | $83M | $84M | $71M | -- | |
Stock-Based Compensation | $17M | $19M | $19M | $20M | -- | |
Change in Accounts Receivable | -$79M | -$6M | $43M | $96M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $17M | $45M | $164M | $324M | -- | |
Capital Expenditures | $21M | $21M | $40M | $23M | -- | |
Cash Acquisitions | -$375M | $6M | -$4M | -- | -- | |
Cash From Investing | -$396M | -$8M | -$44M | -$21M | -- | |
Dividends Paid (Ex Special Dividend) | -$48M | -$49M | -$50M | -$51M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $380M | $455M | $200M | -- | -- | |
Long-Term Debt Repaid | -$27M | -$407M | -$325M | -$5M | -- | |
Repurchase of Common Stock | -$3M | -$2M | -- | -$114M | -- | |
Other Financing Activities | $1M | -$1M | -$2M | -$2M | -- | |
Cash From Financing | $313M | $6M | -$164M | -$159M | -- | |
Beginning Cash (CF) | $534M | $428M | $379M | $547M | -- | |
Foreign Exchange Rate Adjustment | -- | -$5M | $1M | -- | -- | |
Additions / Reductions | -$66M | $43M | -$44M | $144M | -- | |
Ending Cash (CF) | $468M | $339M | $329M | $823M | -- | |
Levered Free Cash Flow | -$4M | $24M | $124M | $301M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $719M | $731M | $680M | $327M | $1.3B | |
Depreciation & Amoritzation | $298M | $333M | $330M | $318M | $290M | |
Stock-Based Compensation | $62M | $68M | $75M | $79M | $86M | |
Change in Accounts Receivable | -$226M | -$227M | -$108M | -$180M | -$185M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.2B | $887M | $801M | $1.4B | $1.3B | |
Capital Expenditures | $165M | $106M | $140M | $185M | $154M | |
Cash Acquisitions | -$1.2B | -$397M | -$184M | -$4M | -- | |
Cash From Investing | -$1.4B | -$507M | -$331M | -$184M | -$152M | |
Dividends Paid (Ex Special Dividend) | -$195M | -$200M | -$198M | -$204M | -$208M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $4.1B | $455M | $2B | -- | $997M | |
Long-Term Debt Repaid | -$3.6B | -$107M | -$2.2B | -$338M | -$543M | |
Repurchase of Common Stock | -$196M | -$673M | -$59M | -$386M | -$1.3B | |
Other Financing Activities | -$2M | -$2M | -$13M | -$9M | -$18M | |
Cash From Financing | $142M | -$484M | -$403M | -$886M | -$966M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$31M | -$104M | $67M | $306M | $219M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $1B | $781M | $661M | $1.2B | $1.2B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $375M | $349M | $374M | $607M | $365M | |
Depreciation & Amoritzation | $157M | $168M | $166M | $140M | $69M | |
Stock-Based Compensation | $32M | $35M | $37M | $40M | $21M | |
Change in Accounts Receivable | -$89M | -$238M | -$123M | -$185M | -$246M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $256M | $138M | $66M | $437M | $58M | |
Capital Expenditures | $47M | $49M | $79M | $40M | $22M | |
Cash Acquisitions | -$593M | $13M | -$4M | -- | -- | |
Cash From Investing | -$640M | -$29M | -$83M | -$33M | -$22M | |
Dividends Paid (Ex Special Dividend) | -$98M | -$100M | -$100M | -$104M | -$53M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $380M | $530M | $1.9B | -- | $997M | |
Long-Term Debt Repaid | -$53M | -$434M | -$2B | -$9M | -$529M | |
Repurchase of Common Stock | -$126M | -$528M | -$43M | -$297M | -$528M | |
Other Financing Activities | $39M | -$3M | -$10M | -$3M | -$12M | |
Cash From Financing | $165M | -$513M | -$221M | -$387M | -$110M | |
Beginning Cash (CF) | $1.2B | $1.3B | $1.1B | $1.3B | $991M | |
Foreign Exchange Rate Adjustment | -- | -$5M | $3M | -$4M | $7M | |
Additions / Reductions | -$219M | -$404M | -$238M | $17M | -$74M | |
Ending Cash (CF) | $1B | $767M | $708M | $1.4B | $842M | |
Levered Free Cash Flow | $209M | $89M | -$13M | $397M | $36M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.